Longevity & Aging Newsletter
Issue #54September 14, 20267 studies

Calorie-restricted mice accumulated fewer DNA mutations across several tissues, study finds

A mouse study connects calorie restriction with fewer accumulated DNA mutations.

Elsewhere, researchers tested approaches to aging-related changes in cells and animals, while small human studies raised questions about how to interpret biological signals.

🧬 Fewer Calories, Fewer Mutations

  • Using high-fidelity DNA sequencing across liver, kidney, and brain tissue, researchers found that calorie-restricted mice accumulated fewer DNA mutations overall — both substitutions and small insertions or deletions — compared to normally fed controls.
  • The reduction wasn't uniform: the biggest drop happened in genomic regions that are transcriptionally quiet, and the effect size varied by tissue type.
  • Caloric restriction also dampened activity of a mutational process called SBS5, which is responsible for the majority of mutations that accumulate in mammalian cells over a lifetime.

Why it matters: This positions genomic stability — how well a cell maintains its DNA — as something diet can actually move, not just a fixed feature of aging.

🏆 Top 0.1% journal 🔗 Cell Journal Article 🗓️ Sep 9

Key Findings

🛡️ A Cancer Drug Trick May Clear Aging Cells

  • A protein called PD-L2 — best known as an immune checkpoint in cancer — turns out to be elevated on senescent cells, helping them hide from immune clearance as we age.
  • Old mice lacking PD-L2 had fewer senescent cells, better insulin sensitivity, and stronger grip strength; treating aged wild-type mice with an anti-PD-L2 antibody restored insulin sensitivity.
💡 Repurposing immune checkpoint biology may offer a new route to clearing aging cells.
🥇 Top 1% journal 🔗 Cell metabolism Journal Article 🗓️ Sep 10

A leucine-derived candidate preserved muscle function in preclinical models

  • In human muscle cells, a leucine-derived compound restored drug-suppressed protein synthesis more strongly than the L-leucine comparison.
  • In a rat model of drug-induced muscle wasting, 14 days of treatment preserved muscle mass and function. The comparison used different administration routes, which matters when interpreting the apparent advantage. These preclinical findings do not establish benefit in people with age-related muscle loss.
💡 Encouraging cell and rat results still leave human benefit untested.
🥈 Top 2% journal 🔗 Mol Ther Journal Article 🗓️ Sep 11

An uncontrolled pilot found a brain blood-flow change in APOE4 carriers

  • A single-arm study followed 23 cognitively normal adults aged 45–65, including nine APOE4 carriers, during four weeks of rapamycin treatment. Blood flow increased by more than 15% in multiple brain regions among carriers; non-carriers showed no significant change.
  • Without a placebo group, this small pilot cannot establish treatment efficacy or show that the blood-flow changes prevent future disease.
💡 The exploratory blood-flow finding does not establish protection against future disease.
🥉 Top 5% journal 🔗 J Cereb Blood Flow Metab Journal Article 🗓️ Sep 11

🏃 HIIT Preserved Brain, Heart, and Muscle Function in Aged Female Mice

  • Fourteen weeks of high-intensity interval training in female mice aged 24 months at the end of the study produced a 71% gain in aerobic capacity, a 73% improvement in executive function, and a 17 mmHg drop in systolic blood pressure.
  • HIIT also reduced cardiac fibrosis and inflammatory markers in the hippocampus, and delayed the onset of frailty.
💡 In aged female mice, structured interval training preserved function across three organ systems simultaneously.
🎖️ Top 10% journal 🔗 GeroScience Journal Article 🗓️ Sep 10

🩸 A Rogue HDL Subfraction Linked to Artery Aging

  • A small, electronegative fraction of HDL cholesterol called H5 was elevated in people with cardiovascular disease risk factors and independently associated with thicker artery walls and greater plaque burden in an imaging cohort of 118 participants.
  • In cell and mouse models, H5 triggered DNA damage and cellular senescence in blood vessel lining cells via the p53-p21 signaling axis.
💡 Not all HDL is protective — one subfraction appears linked to vascular aging through a senescence pathway.
🎖️ Top 10% journal 🔗 GeroScience Journal Article 🗓️ Sep 10

🧬 Aging Clocks Agreed in a Drug Trial — But Couldn't Separate Disease from Aging

  • Six different protein-based biological age clocks all predicted lower biological age in patients treated with an experimental anti-fibrotic drug in a 12-week phase 2a trial.
  • The catch: the clocks couldn't distinguish whether the drug was slowing aging itself or simply improving the underlying disease — a fundamental interpretive gap for the field.
💡 Proteomic age clocks showed consistent signals in a trial, but can't yet tell aging effects from disease effects.
🏆 Top 0.1% journal 🔗 Nature biotechnology Journal Article 🗓️ Sep 7

Implications

These papers measure different things: mutations, physical function, blood flow and estimates of biological age. Their signals should not be treated as interchangeable proof of longer life. A central challenge remains distinguishing meaningful changes in aging from improvements in a particular disease or experimental model.

Studies in this issue

Primary sources used for this newsletter.

  1. Rapamycin may increase brain blood flow and change metabolism, inflammation, and gut bacteria in healthy middle-aged people with APOE4
    key findingJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2026-09-11PMID 42723264
  2. Blocking PD-L2 may reduce buildup of aging cells and related decline
    key findingCell metabolism2026-09-10PMID 42721966
  3. D-Amino Acid Prodrug DLMEH May Activate Cell Growth Pathway Through Sestrin2 to Improve Muscle Protein Production in Age-Related Muscle Loss
    key findingMolecular therapy : the journal of the American Society of Gene Therapy2026-09-11PMID 42723280